v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net loss $ (4,747) $ (17,378)
Adjustments to reconcile net loss to net cash used in operating activities:    
Bad debt expense 8 17
Depreciation and amortization 5,360 7,476
Amortization of deferred revenue (489) (1,887)
Asset impairment 1,360 389
(Gain) loss on sale of assets, net (3,599) 259
Gain on insurance recoveries, net 3,342 0
Deferred income taxes 0 (8,784)
Compensation expense - restricted stock 1,431 1,583
Changes in operating assets and liabilities:    
Contracts receivable and retainage, net (6,438) (17,927)
Contracts in progress (8,098) (4,814)
Prepaid expenses, inventory, and other assets (1,693) 303
Accounts payable (2,410) 10,308
Advance billings on contracts (971) 4,665
Deferred revenue (1,538) (5,078)
Deferred compensation 726 393
Accrued expenses and other liabilities (436) (795)
Accrued contract losses (1,620) 3,127
Current income taxes and other 69 207
Net cash used in operating activities (26,427) (27,936)
Cash flows from investing activities:    
Capital expenditures (891) (1,824)
Purchase of held to maturity, short-term investments (7,474) 0
Proceeds from the sale of property, plant and equipment 56,446 2,120
Recoveries from insurance claims 2,165 0
Net cash provided by investing activities 50,246 296
Cash flows from financing activities:    
Tax payments made on behalf of employees from withheld, vested shares of common stock (787) (884)
Payment of financing cost (11) (61)
Payments of dividends on common stock 0 (299)
Proceeds received from borrowings under our Credit Agreement 15,000 0
Repayment of borrowings under our Credit Agreement (15,000) 0
Net cash used in financing activities (798) (1,244)
Net change in cash and cash equivalents 23,021 (28,884)
Cash and cash equivalents at beginning of period 8,983 51,167
Cash and cash equivalents at end of period $ 32,004 $ 22,283

Source